Showing results (691-700 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Fabrice André, Thomas Bachelot, Frederic Commo, et al.
The Lancet. Oncology|April 5, 2017
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trialChristopher R Heery, Geraldine O'Sullivan-Coyne, Ravi A Madan, et al.
The Lancet. Oncology|April 9, 2017
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trialJesus García-Donas, Albert Font, Begoña Pérez-Valderrama, et al.
The Lancet. Oncology|April 25, 2017
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 studyAllen M Chen, Carol Felix, Pin-Chieh Wang, et al.
The Lancet. Oncology|July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control studyNuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
The Lancet. Oncology|July 13, 2019
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trialSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
The Lancet. Oncology|January 18, 2017
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 studyTamas Hickish, Thierry Andre, Lucjan Wyrwicz, et al.
The Lancet. Oncology|January 18, 2017
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trialCsaba Polgár, Oliver J Ott, Guido Hildebrandt, et al.
The Lancet. Oncology|January 18, 2017
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based studyNina Klemann, M Andreas Røder, J Thomas Helgstrand, et al.
The Lancet. Oncology|January 8, 2008
Gastroenteropancreatic neuroendocrine tumoursIrvin M Modlin, Kjell Oberg, Daniel C Chung, et al.
Pageof 336